Literature DB >> 17000453

Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese.

Peir-Haur Hung1, Yen-Ling Chiu, Wei-Chou Lin, Wen-Chih Chiang, Yung-Ming Chen, Shuei-Liong Lin, Kwan-Dun Wu, Tun-Jun Tsai.   

Abstract

BACKGROUND/
PURPOSE: Pauci-immune glomerulonephritis (GN) is an important cause of crescentic GN, acute renal failure and mortality. However, data are limited on the clinical presentation and outcome in antineutrophil cytoplasmic antibody (ANCA) negative patients, especially in Asians.
METHODS: This retrospective study analyzed medical records and pathology slides of patients who received renal biopsy between February 1998 and October 2004. Enzyme-linked immunosorbent assay was used routinely for ANCA testing in all patients.
RESULTS: Among 637 patients with biopsy-proven GN included in this study, 88 (13.8%) had glomerular crescent formation. Among them, pauci-immune crescentic glomerulonephritis (PICGN) (42 patients, 47.2%) and lupus nephritis (25 patients, 28.4%) were the most common pathologic diagnoses. Lupus patients were younger (p = 0.028), while PICGN patients had more chronic lesions (p < 0.001), extensive glomerular crescents (p < 0.001), less severe proteinuria (p < 0.001) and poorer renal survival (p = 0.0017). Among the PICGN patients, 62.5% had a positive ANCA test, 80% had myeloperoxidase-ANCA and 20% had proteinase-3-ANCA. Subgroup analysis showed that ANCA negativity was associated with less crescent formation (p < 0.001) but more chronic glomerular lesions (p < 0.001) and a trend toward worse renal outcome (p = 0.055).
CONCLUSION: This study illustrates the necessity for pathologic diagnosis of pauci-immune GN despite ANCA negativity. The poor prognosis associated with ANCA negativity in this study may be partly due to delayed diagnosis since these patients frequently lacked systemic involvement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000453     DOI: 10.1016/S0929-6646(09)60267-9

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  18 in total

Review 1.  ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Min Chen; Cees G M Kallenberg; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2009-04-28       Impact factor: 28.314

2.  Pauci-immune crescentic glomerulonephritis associated with use of trimethoprim-sulfamethoxazole.

Authors:  Shruti S Hegde; Vanesa Bijol; Bertrand L Jaber
Journal:  CEN Case Rep       Date:  2016-06-07

3.  Clinical, serological and histological determinants of patient and renal outcome in ANCA-associated vasculitis with renal involvement: an analysis from a referral centre.

Authors:  Matija Crnogorac; Ivica Horvatic; Luka Toric; Danica Galesic Ljubanovic; Miroslav Tisljar; Krešimir Galesic
Journal:  Int Urol Nephrol       Date:  2017-06-23       Impact factor: 2.370

4.  Differential deposition of C4d and MBL in glomeruli of patients with ANCA-negative pauci-immune crescentic glomerulonephritis.

Authors:  Guang-qun Xing; Min Chen; Gang Liu; Xin Zheng; Jie E; Ming-hui Zhao
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

5.  A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.

Authors:  Shivani Shah; John Havill; M Hafizur Rahman; Duvuru Geetha
Journal:  Clin Rheumatol       Date:  2015-10-07       Impact factor: 2.980

6.  Distinguishing active from quiescent disease in ANCA-associated vasculitis using attenuated total reflection Fourier-transform infrared spectroscopy.

Authors:  Adam D Morris; Camilo L M Morais; Kássio M G Lima; Daniel L D Freitas; Mark E Brady; Ajay P Dhaygude; Anthony W Rowbottom; Francis L Martin
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

7.  A case of a 6-year-old girl with anti-neutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis.

Authors:  Maki Shimizu; Takanori Sekiguchi; Natsuko Kishi; Aya Goji; Tomoko Takahashi; Hiroko Kozan; Zenichi Sakaguchi; Yukiko Kinoshita; Sato Matsuura; Kenichi Suga; Maki Urushihara; Shuji Kondo; Shoji Kagami; Katsuaki Ohara
Journal:  Clin Exp Nephrol       Date:  2011-03-01       Impact factor: 2.617

8.  Antineutrophil cytoplasmic antibody-negative pauci-immune glomerulonephritis with massive intestinal bleeding.

Authors:  Miyeon Kim; Young Uck Kim; Sun Jin Boo; So Mi Kim; Hyun Woo Kim
Journal:  Kidney Res Clin Pract       Date:  2015-07-28

9.  Recurrence of ANCA-negative renal-limited pauci-immune glomerulonephritis in the renal allograft.

Authors:  Venkatesh Rajkumar; Kiran Krishne Gowda; Vivekanand Jha; Harbir Singh Kohli; Vivek Kumar; Raja Ramachandran
Journal:  Clin Kidney J       Date:  2013-09-03

10.  Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.

Authors:  Sung Woo Lee; Mi-Yeon Yu; Seon Ha Baek; Shin-Young Ahn; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.